|
1
|
Brzezińska A, Bourke J, Rivera-Hernández
R, Tsolaki M, Woźniak J and Kaźmierski J: Depression in dementia or
dementia in depression? Systematic review of studies and
hypotheses. Curr Alzheimer Res. 17:16–28. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Byers A and Yaffe K: Depression and risk
of developing dementia. Nat Rev Neurol. 7:323–331. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
WHO data-updated March 2023. Available
from: https://www.who.int/health-topics/dementia#tab=tab_2.
Accessed on 28 April 2023.
|
|
4
|
GBD 2016 Dementia Collaborators. Global,
regional, and national burden of Alzheimer's disease and other
dementias, 1990-2016: A systematic analysis for the global burden
of disease study 2016. Lancet Neurol. 18:88–106. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Javaid SF, Giebel C, Khan MA and Hashim
MJ: Epidemiology of Alzheimer's disease and other dementias: Rising
global burden and forecasted trends [version 1; peer review: 1
Approved with reservations]. F1000Res. 10(425)2021.
|
|
6
|
Sousa RM, Ferri CP, Acosta D, Albanese E,
Guerra M, Huang Y, Jacob KS, Jotheeswaran AT, Rodriguez JJ,
Pichardo GR, et al: Contribution of chronic diseases to disability
in elderly people in countries with low and middle incomes: A 10/66
dementia research group population-based survey. Lancet.
374:1821–1830. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Barnes DE and Yaffe K: The projected
effect of risk factor reduction on Alzheimer's disease prevalence.
Lancet Neurol. 10:819–828. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Enache D, Winblad B and Aarsland D:
Depression in dementia: Epidemiology, mechanisms, and treatment.
Curr Opin Psychiatry. 24:461–472. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Diniz BS, Butters MA, Albert SM, Dew MA
and Reynolds CF III: Late-life depression and risk of vascular
dementia and Alzheimer's disease: Systematic review and
meta-analysis of community-based cohort studies. Br J Psychiatry.
202:329–335. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Aizenstein HJ, Baskys A, Boldrini M,
Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS,
Meshandin IA, Mijajlovic MD, et al: Vascular depression consensus
report-a critical update. BMC Med. 14(161)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taylor WD, Aizenstein HJ and Alexopoulos
GS: The vascular depression hypothesis: Mechanisms linking vascular
disease with depression. Mol Psychiatry. 18:963–974.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Riddle M, Potter GG, McQuoid DR, Steffens
DC, Beyer JL and Taylor WD: Longitudinal cognitive outcomes of
clinical phenotypes of late-life depression. Am J Geriatr
Psychiatry. 25:1123–1134. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Muliyala KP and Varghese M: The complex
relationship between depression and dementia. Ann Indian Acad
Neurol. 13 (Suppl 2):S69–S73. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Leonard BE: Inflammation, depression and
dementia: Are they connected? Neurochem Res. 32:1749–1756.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ly M and Andreescu C: Advances and
barriers for clinical neuroimaging in late-life mood and anxiety
disorders. Curr Psychiatry Rep. 20(7)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Palsetia D, Rao GP, Tiwari SC, Lodha P and
De Sousa A: The clock drawing test versus mini-mental status
examination as a screening tool for dementia: A clinical
comparison. Indian J Psychol Med. 40:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kørner A, Lauritzen L, Abelskov K, Gulmann
N, Marie Brodersen A, Wedervang-Jensen T and Marie Kjeldgaard K:
The geriatric depression scale and the cornell scale for depression
in dementia. A validity study. Nord J Psychiatry. 60:360–364.
2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ismail Z, Rajji TK and Shulman KI: Brief
cognitive screening instruments: An update. Int J Geriatr
Psychiatry. 25:111–120. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
WMA Declaration of Helsinki-Ethical
Principles for Medical Research Involving Human Subjects-7th
revision, 2013. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
Accessed on 28.04.2023.
|
|
20
|
Livingston G, Huntley J, Sommerlad A, Ames
D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J,
Cooper C, et al: Dementia prevention, intervention, and care: 2020
Report of the lancet commission. Lancet. 396:413–446.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rastad S, Barjaste N, Lanjanian H, Moeini
A, Kiani F and Masoudi-Nejad A: Parallel molecular alteration
between Alzheimer's disease and major depressive disorder in the
human brain dorsolateral prefrontal cortex: An insight from gene
expression and methylation profile analyses. Genes Genet Syst.
97:311–324. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Błaszczyk JW: Pathogenesis of dementia.
Int J Mol Sci. 24(543)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Du F, Yu Q, Swerdlow RH and Waites CL:
Glucocorticoid-driven mitochondrial damage stimulates Tau
pathology. Brain. 146:4378–4394. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Phillips C: Brain-derived neurotrophic
factor, depression, and physical activity: Making the neuroplastic
connection. Neural Plast. 2017(7260130)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rapp MA, Schnaider-Beeri M, Wysocki M,
Guerrero-Berroa E, Grossman HT, Heinz A and Haroutunian V:
Cognitive decline in patients with dementia as a function of
depression. Am J Geriatr Psychiatry. 19:357–363. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Almeida OP, Hankey GJ, Yeap BB, Golledge J
and Flicker L: Depression as a modifiable factor to decrease the
risk of dementia. Transl Psychiatry. 7(e1117)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang Y, Geng R, Liu M, Deng S, Ding J,
Zhong H and Tu Q: Shared peripheral blood biomarkers for
Alzheimer's disease, major depressive disorder, and type 2 diabetes
and cognitive risk factor analysis. Heliyon.
9(e14653)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Réus GZ, Titus SE, Abelaira HM, Freitas
SM, Tuon T, Quevedo J and Budni J: Neurochemical correlation
between major depressive disorder and neurodegenerative diseases.
Life Sci. 158:121–129. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fanelli G, Franke B, De Witte W, Ruisch
IH, Haavik J, van Gils V, Jansen WJ, Vos SJB, Lind L, Buitelaar JK,
et al: Insulinopathies of the brain? Genetic overlap between
somatic insulin-related and neuropsychiatric disorders. Transl
Psychiatry. 12(59)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Harerimana NV, Liu Y, Gerasimov ES, Duong
D, Beach TG, Reiman EM, Schneider JA, Boyle P, Lori A, Bennett DA,
et al: Genetic evidence supporting a causal role of depression in
Alzheimer's disease. Biol Psychiatry. 92:25–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ni H, Xu M, Zhan GL, Fan Y, Zhou H, Jiang
HY, Lu WH, Tan L, Zhang DF, Yao YG and Zhang C: The GWAS risk genes
for depression may be actively involved in Alzheimer's disease. J
Alzheimers Dis. 64:1149–1161. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ghasemi M, Phillips C, Fahimi A, McNerney
MW and Salehi A: Mechanisms of action and clinical efficacy of NMDA
receptor modulators in mood disorders. Neurosci Biobehav Rev.
80:555–572. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yatawara C, Lim L, Chander R, Zhou J and
Kandiah N: Depressive symptoms influence global cognitive
impairment indirectly by reducing memory and executive function in
patients with mild cognitive impairment. J Neurol Neurosurg
Psychiatry. 87:1375–1383. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Holmquist S, Nordström A and Nordström P:
The association of depression with subsequent dementia diagnosis: A
Swedish nationwide cohort study from 1964 to 2016. PLoS Med.
17(e1003016)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gurgu M, Zamfirescu A, Stroie AM and Aurel
R: Cognitive impairment prevalence and correlations with subjective
memory impairment: Findings from Brasov, Romania. J Nutr Health
Aging. 16(862)2012.
|
|
36
|
Kane RL, Butler M, Fink HA, Brasure M,
Davila H, Desai P, Jutkowitz E, McCreedy E, Nelson VA, McCarten JR,
et al: Interventions to prevent age-related cognitive decline, mild
cognitive impairment, and clinical Alzheimer's-type dementia.
Comparative Effectiveness Review No. 188. (Prepared by the
Minnesota Evidence-based Practice Center under Contract No.
290-2015-00008-I.) AHRQ Publication No. 17-EHC008-EF. Rockville,
MD: Agency for Healthcare Research and Quality; March 2017.
www.effectivehealthcare.ahrq.gov/reports/final.cfm.
|
|
37
|
Amidfar M, Garcez ML and Kim YK: The
shared molecular mechanisms underlying aging of the brain, major
depressive disorder, and Alzheimer's disease: The role of circadian
rhythm disturbances. Prog Neuropsychopharmacol Biol Psychiatry.
123(110721)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Morgan SL, Naderi P, Koler K, Pita-Juarez
Y, Prokopenko D, Vlachos IS, Tanzi RE, Bertram L and Hide WA: Most
pathways can be related to the pathogenesis of Alzheimer's disease.
Front Aging Neurosci. 14(846902)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bou Khalil R, Khoury E and Koussa S:
Linking multiple pathogenic pathways in Alzheimer's disease. World
J Psychiatr. 6:208–214. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Du Y, Yan F, Zhao L, Fang Y, Qiu Q, Wei W,
Wang J, Tang Y, Lin X and Li X: Depression symptoms moderate the
relationship between gray matter volumes and cognitive function in
patients with mild cognitive impairment. J Psychiatr Res.
151:516–522. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Botto R, Callai N, Cermelli A, Causarano L
and Rainero I: Anxiety and depression in Alzheimer's disease: A
systematic review of pathogenetic mechanisms and relation to
cognitive decline. Neurol Sci. 43:4107–4124. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bature F, Guinn BA, Pang D and Pappas Y:
Signs and symptoms preceding the diagnosis of Alzheimer's disease:
A systematic scoping review of literature from 1937 to 2016. BMJ
Open. 7(e015746)2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ismail Z, Gatchel J, Bateman DR,
Barcelos-Ferreira R, Cantillon M, Jaeger J, Donovan NJ and Mortby
ME: Affective and emotional dysregulation as pre-dementia risk
markers: Exploring the mild behavioral impairment symptoms of
depression, anxiety, irritability, and euphoria. Int Psychogeriatr.
30:185–196. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Morozova A, Zorkina Y, Abramova O, Pavlova
O, Pavlov K, Soloveva K, Volkova M, Alekseeva P, Andryshchenko A,
Kostyuk G, et al: Neurobiological highlights of cognitive
impairment in psychiatric disorders. Int J Mol Sci.
23(1217)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Oprea VD, Marinescu M, Rișcă Popazu C,
Sârbu F, Onose G and Romila A: Cardiovascular comorbidities in
relation to the functional status and vitamin D levels in elderly
patients with dementia. Diagnostics (Basel).
12(2994)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wang JH, Wu YJ, Tee BL and Lo RY: Medical
comorbidity in Alzheimer's disease: A nested case-control study. J
Alzheimers Dis. 63:773–781. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Weber CJ, Carrillo MC, Jagust W, Jack CR
Jr, Shaw LM, Trojanowski JQ, Saykin AJ, Beckett LA, Sur C, Rao NP,
et al: The worldwide Alzheimer's disease neuroimaging initiative:
ADNI-3 updates and global perspectives. Alzheimer's Dement.
7(e12226)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Li H, Tan CC, Tan L and Xu W: Predictors
of cognitive deterioration in subjective cognitive decline:
Evidence from longitudinal studies and implications for SCD-plus
criteria. J Neurol Neurosurg Psychiatry. 94:844–854.
2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sinclair LI and Ballard CG: Alzheimer's
Disease Neuroimaging Initiative. Persistent depressive symptoms are
associated with frontal regional atrophy in patients with
Alzheimer's disease. Int J Geriatr Psychiatry.
38(e5858)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Walia N, Eratne D, Loi SM, Farrand S, Li
QX, Malpas CB, Varghese S, Walterfang M, Evans AH, Parker S, et al:
Cerebrospinal fluid neurofilament light and cerebral atrophy in
younger-onset dementia and primary psychiatric disorders. Intern
Med J. 53:1564–1569. 2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Dintica CS, Habes M, Erus G, Simone T,
Schreiner P and Yaffe K: Long-term depressive symptoms and midlife
brain age. J Affect Disord. 320:436–441. 2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Gerritsen L, Sigurdsson S, Jonsson PV,
Gudnason V, Launer LJ and Geerlings MI: Depressive symptom profiles
predict dementia onset and brain pathology in older persons. The
AGES-Reykjavik study. Neurobiol Aging. 111:14–23. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Siafarikas N, Alnæs D, Monereo-Sanchez J,
Lund MJ, Selbaek G, Stylianou-Korsnes M, Persson K, Barca ML,
Almdahl IS, Fladby T, et al: Neuropsychiatric symptoms and brain
morphology in patients with mild cognitive impairment and
Alzheimer's disease with dementia. Int Psychogeriatr. 33:1217–1228.
2021.PubMed/NCBI View Article : Google Scholar
|
